David Feltquate - 06 Dec 2024 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Chief Medical Officer
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
Issuer symbol
ITOS
Transactions as of
06 Dec 2024
Transactions value $
$0
Form type
4
Filing time
06 Dec 2024, 18:00:05 UTC
Previous filing
05 Aug 2024
Next filing
29 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITOS Common Stock Award $0 +47K $0.00 47K 06 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. All of the shares of common stock underlying such RSUs will vest on December 6, 2026, subject to the Reporting Person's continued service to the Issuer.